With botanicals like Griffonia Simplicifolia and Mucuna Pruriens, Clarisil Pro touches on an emerging wellness frontier-neuro ...

Twist Bioscience (NASDAQ:TWST) and Ginkgo Bioworks (NYSE:DNA) said on Thursday that they have updated a previous agreement signed in 2022. Under the new three-year $15M deal, Ginkgo will remain a ...

Hundreds of millions of dollars per year are spent by Americans and Europeans on the herbal product Ginkgo biloba, which is purported to boost memory and prevent dementia. Potential mechanisms of ...

CEO Kelly emphasized the flexibility and scalability of Ginkgo's RACs for various applications, including diagnostics. Brendan Smith, TD Cowen, explored AI-driven tools' scalability. Kelly ...

Looking at OpenAI-fueled Azure growth, expanding hybrid cloud environment, and an increased fair value estimate, here’s what we think of Microsoft stock. Maintaining independence and editorial ...

Sarah Theodoroff: Tinnitus is an umbrella term, and there's multiple kinds of tinnitus. Taylor Quimby: Sarah Theodoroff is an audiologist and hearing scientist at VA Portland—that’s VA as in ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Ginkgo Bioworks (NYSE: DNA), which is ...

A major study using AI and population data uncovers how hearing problems and psychological traits combine to drive tinnitus severity, paving the way for early screening and targeted support.

Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against Nicholas J. Pritzker’s other ...